Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Hirsutism causes significant psychological distress in women.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Certain gene variations might be linked to severe acne in women but not in men.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Testosterone is crucial for development, growth, and various body functions in mammals.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Hair aging is inevitable, but using the right hair care products can help maintain hair health.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

New treatments for hair loss are being developed using molecular biology.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.